Cited by 1,039Extracellular vesicles in diseaseNanoparticle-Based Drug DeliveryMesenchymal stem cell research

Advances in therapeutic applications of extracellular vesicles

Open access
Wiklander, Oscar P. B., Brennan, Meadhbh Á., Lötvall, Jan, Breakefield, Xandra O., EL Andaloussi, Samir·2019·Science Translational Medicine

Abstract

Understanding extracellular vesicle biology and production will pave the way for a new type of biotherapeutic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aav8521

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • EVs have surfaced as a promising avenue in the field of theranostics for neurological disorders.

    “In this context, EVs have surfaced as a promising avenue in the field of theranostics [50, 113–117].”

    From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [115]

    The section “EVs AS THERAPEUTIC TOOLS TARGETING HEREDITARY DISEASES” describes EV treatment in mouse models of Parkinson’s disease and explicitly highlights their potential for neurodegenerative disorders. “LOOKING FORWARD” also calls EVs emerging therapeutic entities. These passages support the therapeutic part of the claim, but our copy does not establish a diagnostic role for EVs in neurological disorders, as “theranostics” implies. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wiklander, O. P. B., Brennan, M. Á., Lötvall, J., Breakefield, X. O., & EL Andaloussi, S.
Affiliations
  • Karolinska Institutet (SE)
  • Harvard University (US)
  • University of Gothenburg (SE)
  • Department of Laboratory Medicine, Karolinska Institutet, 141 86 Stockholm, Sweden.
Corresponding author
Wiklander, Oscar P. B.
Venue
Science Translational Medicine
Published
2019-05-15
Volume
11
Issue
492
Pages
eaav8521
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2946298500
Cited by
1,039
References
183
Citations by year
2026: 129 · 2025: 147 · 2024: 164 · 2023: 141 · 2022: 150 · 2021: 178 · 2020: 108 · 2019: 22
FWCI
10.18
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion)
Funders
  • Swedish Cancer Foundation (2014/844 & 2017/739)
  • Swedish Research Council Formas (2016-02854)
  • NIH/NCI (P01 CA069246 & R35 CA232103-01)
  • Swedish Heart and Lung Foundation (20150588)
  • Swedish Strategic science foundation
  • VBG Group Herman Krefting Foundation for Asthma and Allergy Research
  • NIH NCI (U19 CA179563)
  • Marie Skłodowska Curie Individual Fellowship (H2020-MSCA-IF-2015-708711)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
extracellular vesicles, EV-based therapeutics, intercellular communication, tissue regeneration, immunomodulation, drug carriers, nanomedicine
MeSH terms
Extracellular Vesicles, Animals, Disease, Humans, Immunotherapy, Drug Delivery Systems, Bioengineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review